Skip to main content
. 2024 Aug 2;14:1355202. doi: 10.3389/fonc.2024.1355202

Figure 5.

Figure 5

(A) Estimation of viable and dead GECs after treatment with calpain inhibitors 1–2 and calpastatin. (B) Caspase-3 and caspase-7 activity assay performed after GEC treatment. (C) Viability test conducted by MTT on GECs treated with calpain inhibitors 1–2 and calpastatin, alone or in combination with TMZ. Data are the mean±SD of at least three independent experiments run in triplicate. *p<0.05, **p<0.01, ***p<0.001.